Compared to a net loss of Rs 12 crore in FY25, the pharma major reported a consolidated turnaround in its financial performance
The issue comprises a fresh issue of Rs. 95 crore and targeting a total raise of around Rs. 895 crore
he financing was significantly oversubscribed with high demand from both existing and new investors.
The two startups will utilise the capital for business growth including strategic expansion, product development, R&D and technology investments
Precision medicine company advances Raman spectroscopy-based therapeutic drug monitoring platform for rapid, patient-specific dosing solutions
The initiative pairs consumer engagement with a public health message about prevention and early detection
C-CAMP–Imperial College London partnership to boost biotech research, startup exchange, and translational innovation through a five-year collaboration
API maker begins circulation of second and final call money notice for partly paid-up rights shares, completing the last leg of its 2024 fundraising cycle
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
Subscribe To Our Newsletter & Stay Updated
